Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 30/100

Failure Rate

13.3%

2 terminated/withdrawn out of 15 trials

Success Rate

80.0%

-6.5% vs industry average

Late-Stage Pipeline

33%

5 trials in Phase 3/4

Results Transparency

50%

4 of 8 completed trials have results

Key Signals

4 with results

Enrollment Performance

Analytics

Phase 3

4(30.8%)

N/A

3(23.1%)

Phase 2

3(23.1%)

Phase 4

1(7.7%)

Phase 1

1(7.7%)

Early Phase 1

1(7.7%)

13Total

Phase 3(4)

N/A(3)

Phase 2(3)

Phase 4(1)

+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (15)

Showing 15 of 15 trials

NCT05205811Phase 3Completed

The Effects of Combination Zonisamide and Bupropion on Switching to an Electronic Cigarette

Role: collaborator

NCT05994703Phase 2Completed

Assisting Smokers to Switch to an e-Cigarette by Accelerating Learning of Adaptive Habits Using D-cycloserine

Role: collaborator

NCT04188197Not ApplicableCompleted

Assisting Smokers to Switch to a JUUL E-Cigarette by Devaluing Combustible Cigarettes

Role: collaborator

NCT06088862Phase 3Terminated

Evaluate Harm Reduction Products as a Second Line Intervention for Adult Smokers Who Do Not Quit With NRT

Role: collaborator

NCT06063421Not ApplicableNot Yet Recruiting

Comparison of Nicotine Replacement Therapy and Electronic Cigarettes for Smoking Cessation in Pakistan

Role: collaborator

NCT05855343Not ApplicableCompleted

Exploratory Study of Switching From Combustible Cigarettes to the BIDI E-cigarette

Role: collaborator

NCT05825924Phase 3Unknown

Effectiveness of Different THR Products in Adult Population

Role: lead

NCT04933916Phase 1Terminated

Study of EMB-001 as a Potential Smoking Cessation Treatment

Role: collaborator

NCT04188106Phase 4Completed

Efficacy and Tolerability of Combination Varenicline With Hydroxyzine as a Potential Smoking Cessation Treatment

Role: collaborator

NCT05715164Early Phase 1Unknown

Electronic Cigarettes and Nicotine Pouches for Smoking Cessation

Role: collaborator

NCT04388319Phase 3Completed

Zonisamide/Bupropion Effects on Switching to Electronic Cigarettes

Role: collaborator

NCT04210180Phase 2Completed

Combination of E-cigarettes and Varenicline for Tobacco Harm Reduction

Role: collaborator

NCT04826549Completed

A Comparison of Exhaled Carbon Monoxide Measurements Using the iCOquit Smokerlyzer and Vitalograph Breath CO Monitor vs Carboxyhemoglobin From Venous Samples While Validating a Mobile Research Application

Role: collaborator

NCT04523948Unknown

Comparative Tobacco Interventions for Individuals With Severe and Persisting Behavioral Health Disorders

Role: collaborator

NCT04868253Phase 2Unknown

Efficacy and Safety of Combination EMB-001 as a Potential Smoking Cessation Treatment

Role: collaborator

All 15 trials loaded